Cube Labs and academic spin-off focusing on life-science
VALUE CREATION THROUGH DEEP ACADEMIC RELATIONSHIPS
Cube Labs primarily creates, incubates and accelerates academic spin-offs that focusing on whole life-sciences value-creation gamut on molecules to technology platforms and services.
Cube Labs’ expanding network and ecosystem currently comprises more than 650 scientists affiliated to 24 universities and major research institutes in Italy, Europe and increasingly globally. Through the application of its unique Eurocentric business model, Cube Labs offers its portfolio companies invaluable professional guidance and support during the key early years, when the need for risk management coupled to experiences business judgement is highest.
In summary, our business model is a synergistic composite of two value creation activities related to life-sciences innovation. At the early stages of the value chain, we are in essence a life science holding platform operating as an incubator of selected technologies stemming mainly from academia. Later on, we are a market-facing commercial technology-transfer and technology-broker platform. One that seeks to monetize the earlier created value for the optimal benefit of all of our stakeholders.
with partners in Italy, China, US, Poland and Spain and the goal to expand into other strategic countries.
NETWORK OF PROFESSIONALS
with an extended net of universities, academies, research centers, incubators, labs.
the Italian National Institute for Biostructures and Biosystems aggregating up to date 24 universities and more than 650 scientists.
70 R&D companies under management over the years, investment opportunity deal flow for global players through our R&D community
*Le Fonti Awards 2018 excellence of the year: Innovation & Leadership in Life Science - Stock Exchange Market London;
*China Awards 2014: Cube Labs has been awarded with the China AWARDS 2014.
* “Forbes” magazine 11/2018 “Leader in Action”;
* “Fortune” magazine 12/2018 “Briefing Leader”;
* “Millionaire” magazine 02/2019 “Life Science”